Cellavision: Trend is still their friend
Research Update
2024-04-26
07:00
Redeye’s view on the Q1 report. The organic growth was decent, while the gross margin development comprised most of the deviation compared to the results. The cash flow was also strong. We have decreased our sales estimates and adjusted costs slightly for the coming years. We maintain our Base case of SEK 245 (245) and fair value range of SEK 160 – 380 per share
Mats Hyttinge
Analyst Q&A
Closed
Mats Hyttinge answered 3 questions.
Disclosures and disclaimers